Autocal Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 M
as on 05-07-2024
- Revenue %
(FY 2022)
- Profit 56.99%
(FY 2022)
- Ebitda 61.54%
(FY 2022)
- Net Worth -4.66%
(FY 2022)
- Total Assets 10.27%
(FY 2022)
About Autocal Life Science
The Corporate was formerly known as Emerald Calibration Labs Private Limited. The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Vinit Shirsat and Prashant Kamath serve as directors at the Company.
- CIN/LLPIN
U93000MH2013PTC242981
- Company No.
242981
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Vasai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Autocal Life Science Private Limited offer?
Autocal Life Science Private Limited offers a wide range of products and services, including Instrument Calibration & Adjustment, Calibration Services, Instrument Calibration Services.
Who are the key members and board of directors at Autocal Life Science?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinit Shirsat | Director | 10-Apr-2017 | Current |
Prashant Kamath | Director | 10-Apr-2017 | Current |
Financial Performance and Corporate Structure Insights of Autocal Life Science.
Autocal Life Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 56.99% increase in profit. The company's net worth dipped by a decrease of 4.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Autocal Life Science?
In 2022, Autocal Life Science had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sacardande Engineers Private LimitedActive 6 years 9 months
Vinit Shirsat and Prashant Kamath are mutual person
- Autocal Solutions Private LimitedActive 16 years 10 months
Vinit Shirsat and Prashant Kamath are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 06 Aug 2013 | ₹4.50 M | Open |
How Many Employees Work at Autocal Life Science?
Unlock and access historical data on people associated with Autocal Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Autocal Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Autocal Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.